Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption
Authors:
Open Access
- 1 April 2012
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 7, 1819-1827
Abstract
Abstract: In this paper, two novel liver-targeting nanoparticles, norcantharidin-loaded chitosan nanoparticles (NCTD-CS-NPs) and norcantharidin-associated galactosylated chitosan nanoparticles (NCTD-GC-NPs), were prepared using ionic cross-linkage. The physical properties, particle size, encapsulation efficiency, and drug release characteristics of the nanoparticles were investigated in vitro. To investigate the intestinal absorption mechanisms of the two preparations, a series of experiments was carried out, including in situ circulation method, in vitro everted gut sacs, and Ussing chamber perfusion technique. The absorption rate constants (Ka) of NCTD at different segments were found to be duodenum > jejunum > ileum > colon. The concentration had no distinctive effect on absorption kinetics, suggesting that drug absorption is not dose-dependent. The transport of NCTD was found to be inhibited by P-glycoprotein (P-gp) inhibitor, indicating that NCTD might be the substrate of P-gp. The order of the absorption enhancer effects were as follows: low molecular weight chitosan (CS-8kDa) . high molecular weight chitosan (CS-30kDa) > Poloxamer > sodium dodecyl sulfate (SDS) > sodium deoxycholate (SDCh). The results indicate that the chitosan nanoparticles can improve intestinal absorption of NCTD.Keywords
This publication has 41 references indexed in Scilit:
- Absorption, conjugation and efflux of the flavonoids, kaempferol and galangin, using the intestinal CaCo-2/TC7 cell modelJournal of Functional Foods, 2009
- Mechanism of Inhibition of P-Glycoprotein Mediated Efflux by Vitamin E TPGS: Influence on ATPase Activity and Membrane FluidityMolecular Pharmaceutics, 2007
- Intestinal drug efflux: formulation and food effectsAdvanced Drug Delivery Reviews, 2001
- Comparison of the Lymphatic Transport of Halofantrine Administered in Disperse Systems Containing Three Different Unsaturated Fatty AcidsPharmaceutical Research, 2001
- Flux Measurements across Caco-2 Monolayers May Predict Transport in Human Large Intestinal TissueJournal of Pharmaceutical Sciences, 1996
- Intestinal Absorption of Azetirelin, a New Thyrotropin-Releasing Hormone (TRH) Analogue. II. In Situ and in Vitro Absorption Characteristics of Azetirelin from the Rat Intestine.Biological and Pharmaceutical Bulletin, 1995
- The Influence of Peptide Structure on Transport Across Caco-2 Cells. II. Peptide Bond Modification Which Results in Improved PermeabilityPharmaceutical Research, 1992
- Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitroLeukemia Research, 1991
- Desolvation Energy: A Major Determinant of Absorption, But Not Clearance, of Peptides in RatsPharmaceutical Research, 1991
- Medical uses of mylabris in ancient China and recent studiesJournal of Ethnopharmacology, 1989